| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0019 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |